An analysis of National Survey on Drug Use and Health (NSDUH) data showed that individuals with opioid use disorder have 1.88 ...

Nearly all Americans are aware of the U.S. opioid crisis. Overdose deaths increased sixfold between 2003 and 2023, from 12,940 to 79,358. Yearly increases have been especially steep since 2013, when ...

Lofexidine is administered during the period of peak withdrawal symptoms. The Food and Drug Administration (FDA) has approved Lofexidine Tablets 0.18mg, the first generic of Lucemyra. Lofexidine is a ...

EVERETT, Wash. — The Everett Fire Department’s Emergency Medical Services Division (EMS) has launched a new pilot programto allow paramedics to administer buprenorphine, to help with opiate withdrawal ...

Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.

A collaboration with Virginia Tech supports recognizing remission as a treatment outcome-capturing symptoms, quality of life, and functional outcomes-beyond abstinence aloneOf all MOUD, monthly ...